Qube Research & Technologies LTD Personalis, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Personalis, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 109 shares of PSNL stock, worth $536. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 3,216
96.61%
Holding current value
$536
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PSNL
# of Institutions
78Shares Held
22.4MCall Options Held
27.5KPut Options Held
0-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.09MShares$34.9 Million0.36% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.9MShares$9.37 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.03MShares$5.06 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.793KShares$3.9 Million0.0% of portfolio
About Personalis, Inc.
- Ticker PSNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 45,918,400
- Market Cap $226M
- Description
- Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...